| The projected economic and health burden of uncontrolled asthma in the United States M Yaghoubi, A Adibi, A Safari, JM FitzGerald, M Sadatsafavi American journal of respiratory and critical care medicine 200 (9), 1102-1112, 2019 | 54 | 2019 |
| Validation and Utility Testing of Clinical Prediction Models: Time to Change the Approach A Adibi, M Sadatsafavi, JPA Ioannidis JAMA, 2020 | 27 | 2020 |
| Cell Therapy for Intracranial Aneurysms: A Review A Adibi, A Sen, AP Mitha World neurosurgery 86, 390-398, 2016 | 13 | 2016 |
| Combined endovascular coiling and intra-aneurysmal allogeneic mesenchymal stromal cell therapy for intracranial aneurysms in a rabbit model: a proof-of-concept study A Adibi, M Eesa, JH Wong, A Sen, AP Mitha Journal of neurointerventional surgery 9 (7), 707-712, 2017 | 11 | 2017 |
| The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study A Adibi, DD Sin, A Safari, KM Johnson, SD Aaron, JM FitzGerald, ... The Lancet Respiratory Medicine 8 (10), 1013-1021, 2020 | 7 | 2020 |
| Development and validation of the Evaluation Platform In COPD (EPIC): a population-based outcomes model of COPD for Canada M Sadatsafavi, S Ghanbarian, A Adibi, K Johnson, JM FitzGerald, ... Medical Decision Making 39 (2), 152-167, 2019 | 6 | 2019 |
| Looking at the COPD spectrum through “PRISm” A Adibi, M Sadatsafavi European Respiratory Journal 55 (1), 2020 | 4 | 2020 |
| Cost effectiveness of case detection strategies for the early detection of COPD KM Johnson, M Sadatsafavi, A Adibi, L Lynd, M Harrison, H Tavakoli, ... Applied Health Economics and Health Policy 19 (2), 203-215, 2021 | 3 | 2021 |
| An individualized prediction model for long-term lung function trajectory and risk of COPD in the general population W Chen, DD Sin, JM FitzGerald, A Safari, A Adibi, M Sadatsafavi Chest 157 (3), 547-557, 2020 | 3 | 2020 |
| Cost-effectiveness of implementing objective diagnostic verification of asthma in the United States M Yaghoubi, A Adibi, Z Zafari, JM FitzGerald, SD Aaron, KM Johnson, ... Journal of Allergy and Clinical Immunology 145 (5), 1367-1377. e4, 2020 | 2 | 2020 |
| Lowering the P Value Threshold A Adibi, D Sin, M Sadatsafavi JAMA 321 (15), 1532-1533, 2019 | 2 | 2019 |
| Mesenchymal stromal cells: Translational pathways to clinical adoption H Peiman, S Viswanathan Academic Press, 2016 | 1 | 2016 |
| Combined Coiling and Allogeneic Mesenchymal Stem/Stromal Cell Therapy Could be a More Cost-effective Alternative to Coiling Alone A Adibi, A Sen, AP Mitha STROKE 47, 2016 | 1* | 2016 |
| Testing Clinical Prediction Models—Reply A Adibi, M Sadatsafavi, JPA Ioannidis JAMA 324 (19), 2000-2000, 2020 | | 2020 |
| Development of a Conceptual Model of Childhood Asthma to Inform Asthma Prevention Policies A Adibi, SE Turvey, TY Lee, MR Sears, AB Becker, PJ Mandhane, ... medRxiv, 2020 | | 2020 |
| PRISM: Decision-Analytic Models on the Cloud M Sadatsafavi, A Adibi 41st Annual Meeting of the Society for Medical Decision Making, 2019 | | 2019 |
| The projected economic and health burden of uncontrolled asthma in the United States: Supplementary Material Y Mohsen, A Adibi, A Safari, JM FitzGerald, M Sadatsafavi | | 2019 |
| Development, Validation, and Implementation of Evaluation Platform in COPD (EPIC): A Population-Based Microsimulation Outcomes Model of COPD for Canada M Sadatsafavi, S Ghanbarian, A Adibi, JM FitzGerald, W Flanagan, ... 40th Annual Meeting of the Society for Medical Decision Making, 2018 | | 2018 |
| Conceptualization, Development, And Internal And External Validation of A ‘Whole Disease’Model for Chronic Obstructive Pulmonary Disease S Ghanbarian, D Sin, A Adibi, JM FitzGerald, S Bryan, M Sadatsafavi Value in Health 20 (9), A735, 2017 | | 2017 |
| MSCs Translational Process S Viswanathan, A Adibi, S Bhatt Mesenchymal Stromal Cells, 1-35, 2017 | | 2017 |
Mohsen SadatsafaviAssociate Professor, the University of British ColumbiaVerified email at mail.ubc.ca
